Functional Analysis and Experimental Validation of the Prognostic and Immune Effects of the Oncogenic Protein CDC45 in Breast Cancer
The expression level of CDC45 is linked to the prognosis, immune infiltration, and drug sensitivity of BC. In vitro and in vivo experiments have confirmed that CDC45 acts as a cancer-promoting protein in breast cancer.
Authors
- Manqing Cao
- Xin Liu (ORCID: https://orcid.org/0000-0003-0727-5659)
- Shasha Liu (ORCID: https://orcid.org/0000-0002-7236-1716)
- Hong Liu (ORCID: https://orcid.org/0000-0002-3985-9504)
- Linwei Li (ORCID: https://orcid.org/0000-0002-0828-3610)
- Jianing Zhang (ORCID: https://orcid.org/0000-0002-3591-0368)
- Zi-Lu Yi
Institutions
- Tianjin Medical University Cancer Institute and Hospital (CN)
Publication Details
- Journal
- Breast Cancer Targets and Therapy
- Published
- 2025-01-01
- DOI
- https://doi.org/10.2147/bctt.s497975
- Primary Topic
- Epigenetics and DNA Methylation
- Type
- article
- Field-Weighted Citation Impact
- 0.00